Suppr超能文献

对患者使用氯胺酮及其抗抑郁特性的体验进行定性和定量描述。

A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant properties.

机构信息

School of Pharmacy, University of Auckland, Auckland, New Zealand.

Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.

出版信息

J Psychopharmacol. 2021 Aug;35(8):946-961. doi: 10.1177/0269881121998321. Epub 2021 Mar 30.

Abstract

BACKGROUND

Ketamine is central to one of the most rapidly growing areas of neuroscientific research into novel treatments for depression. Limited research has indicated that the psychedelic properties of ketamine may play a role in its antidepressant effects.

AIM

The aim of the current study was to explore the psychedelic experiences and sustained impact of ketamine in major depressive disorder.

METHODS

In the current study, ketamine (0.44 mg/kg) was administered to 32 volunteers with major depressive disorder in a crossover design with the active-placebo remifentanil, in a magnetic resonance imaging (MRI) environment. The 11-dimension altered states of consciousness questionnaire and individual qualitative interviews were used to capture the acute psychedelic experience. The Montgomery-Asberg Depression Rating Scale and further interviewing explored lasting effects. The second qualitative interview took place ⩾3 weeks post-ketamine.

RESULTS

Greater antidepressant response (reduction in Montgomery-Asberg Depression Rating Scale at 24 h) correlated with the 11-dimension altered states of consciousness dimensions: spirituality, experience of unity, and insight. The first qualitative interview revealed that all participants experienced perceptual changes. Additional themes emerged including loss of control and emotional and mood changes. The final interview showed evidence of a psychedelic afterglow, and changes to perspective on life, people, and problems, as well as changes to how participants felt about their depression and treatments.

CONCLUSIONS

The current study provides preliminary evidence for a role of the psychedelic experience and afterglow in ketamine's antidepressant properties. Reflexive thematic analysis provided a wealth of information on participants' experience of the study and demonstrated the psychedelic properties of ketamine are not fully captured by commonly used questionnaires.

摘要

背景

氯胺酮是神经科学领域中研究用于治疗抑郁症的新型治疗方法的最快速发展领域之一的核心。有限的研究表明,氯胺酮的迷幻特性可能在其抗抑郁作用中发挥作用。

目的

本研究旨在探索氯胺酮治疗重度抑郁症患者的迷幻体验和持续影响。

方法

在本研究中,32 名重度抑郁症患者以交叉设计接受氯胺酮(0.44mg/kg)或活性安慰剂瑞芬太尼治疗,并在磁共振成像(MRI)环境下进行。使用 11 维度改变意识状态问卷和个体定性访谈来捕捉急性迷幻体验。使用蒙哥马利-阿斯伯格抑郁评定量表和进一步的访谈来探索持久的影响。第二次定性访谈发生在氯胺酮治疗后 ⩾3 周。

结果

更大的抗抑郁反应(24 小时时蒙哥马利-阿斯伯格抑郁评定量表的降低)与 11 维度改变意识状态维度相关:精神性、统一体验和洞察力。第一次定性访谈显示,所有参与者都经历了知觉变化。其他主题包括失去控制和情绪和情绪变化。最终的访谈显示,存在迷幻余辉,以及对生活、人和问题的看法的改变,以及参与者对自己的抑郁和治疗的看法的改变。

结论

本研究为氯胺酮的抗抑郁特性与迷幻体验和余辉有关提供了初步证据。反思性主题分析提供了参与者对研究体验的丰富信息,并表明常用问卷并未完全捕捉到氯胺酮的迷幻特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验